Sikkim Journal

Contact Dermatitis (CD) Disease Understanding and Treatment Market by DelveInsight

 Breaking News
  • No posts were found

Contact Dermatitis (CD) Disease Understanding and Treatment Market by DelveInsight

August 27
16:36 2021
Contact Dermatitis (CD) Disease Understanding and Treatment Market by DelveInsight

The Contact Dermatitis market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Contact Dermatitis (CD) market size from 2017 to 2030. The report also covers current Contact Dermatitis (CD) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

 

Contact Dermatitis Overview

Contact dermatitis (CD) is a type of eczema triggered by contact with a particular substance in the environment that the person is allergic to, it may react by causing the skin to itch and become red. Eczema is the name for a group of conditions that cause skin to become dry and irritated. CD usually improves or clears up completely if the substance causing the problem is identified and avoided. Treatments are also available to help ease the symptoms.

 

Request free sample copy- https://www.delveinsight.com/sample-request/contact-dermatitis-market

 

List of regions covered in the report

• The United States

• EU5 (Germany, France, Italy, Spain, and the United Kingdom)

• Japan

 

List of key players involved in the report

  • Edesa Biotech
  • Hapten Sciences
  • And many others

 

Contact Dermatitis Symptoms

Clinical symptoms depend primarily on whether the dermatitis is acute or chronic, as well as on the toxin involved, type of contact, pathomechanism, and localization, among other factors. Although all types of dermatitis generally share common features, the classic eczematous stages in CD are most readily identifiable.

Acute CD is characterized by pathological symptoms over the entire lesion:

• Mild form: erythema at the site of exposure to the toxin, contact traces, and itching are possible.

• Severe form: ranging from vesicular papules to blisters, usually causing strong itching. A feeling of tightness of the skin and even pain may occur. Blister rupture is followed by weeping, scab formation, and later by scaliness. Spreading reactions are possible in the case of an allergic trigger.

 

Contact Dermatitis Diagnosis

The diagnosis of CD is most often made with history and physical examination findings. Irritant and allergic CD may be complicated by bacterial superinfection, and bacterial culture should be considered with the presence of exudate, weeping, and crusting. A potassium hydroxide (KOH) preparation is useful if tinea or Candida infection is suspected, because these fungal infections can have erythema and scaling similar to contact dermatitis. If the KOH preparation has negative results but a fungal etiology is still suspected, a fungal culture should be sent for laboratory testing. Dermoscopy and microscopy can be used to look for scabies and mites.

 

Contact Dermatitis Treatment

In patients with contact dermatitis, the priority is to identify and avoid the causative substance. Cool compresses can soothe the symptoms of acute contact dermatitis, and calamine lotion and colloidal oatmeal baths may help dry and soothe acute, oozing lesions.

Localized acute allergic CD lesions are successfully treated with mid- or high-potency topical steroids, such as triamcinolone 0.1% (Kenalog, Aristocort) or clobetasol 0.05% (Temovate). On areas with thinner skin (e.g., flexural surfaces, eyelids, face, anogenital region), lower-potency steroids, such as desonide ointment (Desowen), can be helpful and minimize the risk of skin atrophy. There are insufficient data to support the use of topical steroids for irritant contact dermatitis. However, because it is difficult to clinically distinguish between allergic and irritant contact dermatitis, these agents are often used successfully for the irritant form as well.

 

Contact Dermatitis Types

There are two most common types of CD, namely, Irritant Contact Dermatitis (ICD) and Allergic contact dermatitis (ACD). ICD is more common (80%) and can occur in anyone, especially after repeated exposure. ACD, on the other hand, is seen in genetically predisposed and previously sensitized individuals who react to even low concentrations of the agent. Cosmetics, medicines, clothes dyes, as well as foods, rubber and poison ivy are common causes of ACD.

 

Contact Dermatitis Market Report Highlights

  • CD may be complicated by bacterial superinfection, and bacterial culture should be considered with the presence of exudate, weeping, and crusting.
  • The diagnosis of CD is most often made with history, physical examination findings and patch testing.
  • In a meta-analysis, the most prevalent allergens detected using the TRUE Test were nickel (14.7% of patients), thimerosal (5.0%), cobalt (4.8%), fragrance mix (3.4%), and balsam of Peru (3.0%). The TRUE Test may miss some important antigens, however.

 

Contact Dermatitis Market Insights

In patients with CD, the priority is to identify and avoid the causative substance. Cool compresses can soothe the symptoms of acute CD, and calamine lotion and colloidal oatmeal baths may help dry and soothe acute, oozing lesions.

 

Contact Dermatitis Market Forecast

Till date, there is no approved therapy specific for CD. The treatment paradigm is mostly similar to that of Atopic Dermatitis. Therefore, the current treatment of CD is mainly dominated by the use of off-label therapies, which includes Topical Corticosteroids (Clobetasol and Triamcinolone) and Emollients, Topical Immunosupressants (Pimecromilus and Tacrolimus), Systemic Immunosupressants (Antihistamines) and Corticosteroids and Others (Antiseptics, Topical Antibiotics, Phototherapy and Other Immunosupressants).

 

Contact Dermatitis Market Report Scope

• The report covers the descriptive overview of Contact Dermatitis (CD), explaining its causes, signs and symptoms, pathogenesis and currently available therapies.

• Comprehensive insight has been provided into the Contact Dermatitis (CD) epidemiology and treatment.

• Additionally, an all-inclusive account of both the current and emerging therapies for Contact Dermatitis (CD) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.

• A detailed review of Contact Dermatitis (CD) market; historical and forecasted is included in the report, covering the 7MM drug outreach.

• The report provides an edge while developing business strategies, by understanding trends shaping and driving the 7MM Contact Dermatitis (CD) market.

 

Request free sample copy- https://www.delveinsight.com/sample-request/contact-dermatitis-market

 

Table of content

1. Key Insights

2. Executive Summary of Contact Dermatitis

3. Competitive Intelligence Analysis for Contact Dermatitis

4. Contact Dermatitis : Market Overview at a Glance

5. Contact Dermatitis : Disease Background and Overview

6. Patient Journey

7. Contact Dermatitis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Contact Dermatitis Treatment

11. Marketed Products

12. Emerging Therapies

13. Contact Dermatitis : Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Contact Dermatitis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Contact Dermatitis Market Drivers

  • Futuristic Market Opportunity for Key Players
  • Potential Emerging Treatment Option (EB01)
  • High Potential of Market Growth due to Large Target Patient Pool
  • Low Cost of Treatment

 

Contact Dermatitis Market Barriers

  • Inadequate Reimbursement Scenario
  • Barriers to Patch Testing
  • Lack of Significant Disease Management
  • The Dominance of off-label Therapies
  • Lack of Treatment Pattern Studies

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Related Articles